Anti-tuberculosis drug
- 总结
- PPI-benzimidazole analogues for the treatment of multidrug-resistant tuberculosis.
- 技术优势
- Active against multidrug-resistant tuberculosis
Small molecule
Tested in-vitro and in-vivo
SAR data available
- 技术应用
- new drug to treat Mtb infections.
- 详细技术说明
- he inventors were able to demonstrate that lansoprazole and derivatives thereof exhibit growth inhibiting properties against intracellular Mtb. In particular, it has been proven that the reduced form lansoprazole sulfide is the active moiety. Yet, lansoprazole is not metabolized in a sufficient amount to serve as a prodrug. Thus, the inventors propose lansoprazole sulfide (LPZS) as a new drug to treat Mtb infections.
- 合作类型
- Licensing
- 申请日期
- 26/01/2016 00:00:00
- 申请号码
- EP20160701631 20160126
- 分类
- - international:
A61K31/4439; A61K45/06; A61P31/06
- cooperative:
default
A61K31/4439; A61K45/06; A61P31/06; C07D401/12; A61K2300/00
C-sets
A61K31/4439, A61K2300/00
- 其他
- Patent application
- ID号码
- 5126
- 国家/地区
- 德国
欲了解更多信息，请点击 这里
